| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6156742 | TEVA BRANDED PHARM | Emergency contraceptive kit |
Dec, 2020
(3 years ago) | |
Preven Emergency Contraceptive Kit is owned by Teva Branded Pharm.
Preven Emergency Contraceptive Kit contains Ethinyl Estradiol; Levonorgestrel.
Preven Emergency Contraceptive Kit has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Preven Emergency Contraceptive Kit are:
- US6156742
Preven Emergency Contraceptive Kit was authorised for market use on 01 September, 1998.
Preven Emergency Contraceptive Kit is available in tablet;oral dosage forms.
Preven Emergency Contraceptive Kit can be used as kit adapted and designed to provide both data on the current reproductive status of a patient and contraception for those who are not pregnant, but recently engaged in unprotected sex.
The generics of Preven Emergency Contraceptive Kit are possible to be released after 05 December, 2020.
Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient
Market Authorisation Date: 01 September, 1998
Treatment: Kit adapted and designed to provide both data on the current reproductive status of a patient and contraception for those who are not pregnant, but recently engaged in unprotected sex
Dosage: TABLET;ORAL
PREVEN EMERGENCY CONTRACEPTIVE KIT family patents
